NCT06601803View on ClinicalTrials.gov

Surgiphor Us in TSA

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Total Shoulder ArthroplastyShoulder InfectionPovidone Iodine
Interventions
DRUG

sterile saline solution

The shoulder will be washed with normal sterile saline before and after placing the shoulder implant

DRUG

Surgiphor

The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant

PROCEDURE

Sample Collection

During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure

Trial Locations (1)

19107

Rothman Orthopaedic Institute, Philadelphia

All Listed Sponsors
lead

Rothman Institute Orthopaedics

OTHER

NCT06601803 - Surgiphor Us in TSA | Biotech Hunter | Biotech Hunter